Med. praxi 2013; 10(8-9): 277-278

Acarbose in the general practitioner’s surgery

MUDr.Marcela Szabó
Diabetologická ambulance, Poliklinika Barrandov, Praha

Acarbose is an oral antidiabetic that, for decades, has expanded the options of pharmacological treatment in diabetic patients. Acarbose

inhibits intestinal alpha-glucosidase, an enzyme assuring saccharide breakdown. As a result, polysaccharide and oligosaccharide

breakdown and monosaccharide absorption become slower, which results in a reduction in postprandial glucose elevation.

Keywords: acarbose, intestinal alpha-glucosidase inhibition, saccharide breakdown, prevention of postprandial hyperglycaemia, dyspeptic complaints

Published: September 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Szabó M. Acarbose in the general practitioner’s surgery. Med. praxi. 2013;10(8-9):277-278.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Česká diabetologická společnost. Doporučený postup péče o pacienty s diabetes mellitus 2. typu-2012. http://www.diab.cz/standardy/.
    2. Glucobay: souhrn údajů o přípravku 16. 12. 2009.
    3. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care. 1998; 21(10): 1720-1725. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.